Suchergebnisse

Background CT is the most common imaging modality in traumatic brain injury (TBI). However, its conventional use requires expert clinical interpretation and does not provide detailed quantitative outputs, which may have prognostic importance. We aimed to use deep learning to reliably and efficiently quantify and detect different lesion types. Methods Patients were recruited between Dec 9, 2014, and Dec 17, 2017, in 60 centres across Europe. We trained and validated an initial convolutional neural network (CNN) on expert manual segmentations (dataset 1). This CNN was used to automatically segment a new dataset of scans, which we then corrected manually (dataset 2). From this dataset, we used a subset of scans to train a final CNN for multiclass, voxel-wise segmentation of lesion types. The performance of this CNN was evaluated on a test subset. Performance was measured for lesion volume quantification, lesion progression, and lesion detection and lesion volume classification. For lesion detection, external validation was done on an independent set of 500 patients from India. Findings 98 scans from one centre were included in dataset 1. Dataset 2 comprised 839 scans from 38 centres: 184 scans were used in the training subset and 655 in the test subset. Compared with manual reference, CNN-derived lesion volumes showed a mean difference of 0·86 mL (95% CI –5·23 to 6·94) for intraparenchymal haemorrhage, 1·83 mL (–12·01 to 15·66) for extra-axial haemorrhage, 2·09 mL (–9·38 to 13·56) for perilesional oedema, and 0·07 mL (–1·00 to 1·13) for intraventricular haemorrhage. Interpretation We show the ability of a CNN to separately segment, quantify, and detect multiclass haemorrhagic lesions and perilesional oedema. These volumetric lesion estimates allow clinically relevant quantification of lesion burden and progression, with potential applications for personalised treatment strategies and clinical research in TBI. Funding European Union 7th Framework Programme, Hannelore Kohl Stiftung, OneMind, NeuroTrauma Sciences, Integra Neurosciences, European Research Council Horizon 2020

BACKGROUND: We aimed to understand the relationship between serum biomarker concentration and lesion type and volume found on computed tomography (CT) following all severities of TBI. METHODS: Concentrations of six serum biomarkers (GFAP, NFL, NSE, S100B, t-tau and UCH-L1) were measured in samples obtained <24 hours post-injury from 2869 patients with all severities of TBI, enrolled in the CENTER-TBI prospective cohort study (NCT02210221). Imaging phenotypes were defined as intraparenchymal haemorrhage (IPH), oedema, subdural haematoma (SDH), extradural haematoma (EDH), traumatic subarachnoid haemorrhage (tSAH), diffuse axonal injury (DAI), and intraventricular haemorrhage (IVH). Multivariable polynomial regression was performed to examine the association between biomarker levels and both distinct lesion types and lesion volumes. Hierarchical clustering was used to explore imaging phenotypes; and principal component analysis and k-means clustering of acute biomarker concentrations to explore patterns of biomarker clustering. FINDINGS: 2869 patient were included, 68% (n=1946) male with a median age of 49 years (range 2-96). All severities of TBI (mild, moderate and severe) were included for analysis with majority (n=1946, 68%) having a mild injury (GCS 13-15). Patients with severe diffuse injury (Marshall III/IV) showed significantly higher levels of all measured biomarkers, with the exception of NFL, than patients with focal mass lesions (Marshall grades V/VI). Patients with either DAI+IVH or SDH+IPH+tSAH, had significantly higher biomarker concentrations than patients with EDH. Higher biomarker concentrations were associated with greater volume of IPH (GFAP, S100B, t-tau;adj r2 range:0·48-0·49; p<0·05), oedema (GFAP, NFL, NSE, t-tau, UCH-L1;adj r2 range:0·44-0·44; p<0·01), IVH (S100B;adj r2 range:0.48-0.49; p<0.05), Unsupervised k-means biomarker clustering revealed two clusters explaining 83·9% of variance, with phenotyping characteristics related to clinical injury severity. INTERPRETATION: Interpretation: Biomarker concentration within 24 hours of TBI is primarily related to severity of injury and intracranial disease burden, rather than pathoanatomical type of injury. FUNDING: CENTER-TBI is funded by the European Union 7th Framework programme (EC grant 602150).